-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 SW2EJXqCRIxj8SoG0TK5Kj6f9uB1yc1tsvYZpgpuqXFrICgBuNGnVCyvqap9f5uU
 sFFQlNF26RwAk5gxtAH8Rg==

<SEC-DOCUMENT>0001144204-08-049936.txt : 20080826
<SEC-HEADER>0001144204-08-049936.hdr.sgml : 20080826
<ACCEPTANCE-DATETIME>20080826182730
ACCESSION NUMBER:		0001144204-08-049936
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080822
FILED AS OF DATE:		20080826
DATE AS OF CHANGE:		20080826

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			XTL BIOPHARMACEUTICALS LTD
		CENTRAL INDEX KEY:			0001023549
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	BUSINESS ADDRESS:	
		STREET 1:		711 EXECUTIVE BOULEVARD
		STREET 2:		SUITE Q
		CITY:			VALLEY COTTAGE
		STATE:			NY
		ZIP:			10989
		BUSINESS PHONE:		972-8-930-4440

	MAIL ADDRESS:	
		STREET 1:		711 EXECUTIVE BOULEVARD
		STREET 2:		SUITE Q
		CITY:			VALLEY COTTAGE
		STATE:			NY
		ZIP:			10989

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			WEISS MICHAEL S
		CENTRAL INDEX KEY:			0001038977

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51310
		FILM NUMBER:		081040259

	BUSINESS ADDRESS:	
		STREET 1:		C/O PARAMONT CAPITAL INC
		STREET 2:		787 SEVENTH AVENE 44TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		2125315965

	MAIL ADDRESS:	
		STREET 1:		750 LEXINGTON AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>v124972_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0203</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2008-08-22</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001023549</issuerCik>
        <issuerName>XTL BIOPHARMACEUTICALS LTD</issuerName>
        <issuerTradingSymbol>XTLB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001038977</rptOwnerCik>
            <rptOwnerName>WEISS MICHAEL S</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O XTL BIOPHARMACEUTICALS LTD</rptOwnerStreet1>
            <rptOwnerStreet2>711 EXECUTIVE BLVD., SUITE Q</rptOwnerStreet2>
            <rptOwnerCity>VALLEY COTTAGE,</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10989</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>OPTIONS TO PURCHASE ORDINARY SHARES</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>9250000</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
        <nonDerivativeHolding>
            <securityTitle>
                <value>AMERICAN DEPOSITORY RECEIPTS REPRESENTING 10 ORDINARY SHARES</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>25000</value>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Options to purchase ordinary shares which vest upon achievement of certain market capitalization based milestones (1/3 upon
 the achievement of $150 million market capitalization, 1/3 upon the achievement of $250 million market capitalization, and
 1/3 upon the achievement of $350 million market capitalization, in each case as set out in the option agreement under which
 Mr. Weiss was granted the options). As of the filing date, 3,083,333 options have vested.</footnote>
        <footnote id="F2">On August 22, 2008, Mr. Weiss purchased 5,000 ADRs at a price of  $3.9797 and an additional 5,000 ADRs at a price of $3.98.
 On August 26, 2008, Mr. Weiss purchased 2,270 ADRs at a price of $4.43, 130 ADRs at $4.41, 100 ADRs at $4.39, 5,000 ADRs
 at $4.40, 2,500 ADRs at $4.3932 and 5,000 ADRs at $4.4296.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Michael S. Weiss</signatureName>
        <signatureDate>2008-08-26</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
